Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Mitsui Chemicals patent covers new agents for telomerase-mediated disorders

Jan. 7, 2004

Kirin Brewery presents new inhibitors of Bcl-2/Bcl-xL with utility in cancer therapy

Jan. 7, 2004

Pharmion submits Vidaza NDA

Jan. 7, 2004

Positive proof of concept results for SUDCA

Jan. 5, 2004

CTX granted for phase IIa trial of ATL-104 for mucositis

Jan. 5, 2004

First patient enrolled in trial of dendritic cell vaccine for melanoma

Jan. 5, 2004

Tributyrin induces apoptosis of leukemia cell lines

Dec. 30, 2003

Potential clinical benefits of CAI in ovarian cancer

Dec. 30, 2003

European orphan drug designation for gimatecan for glioma

Dec. 30, 2003

Enrollment completed in phase IIa study of PCK-3145

Dec. 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...